These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16176358)

  • 1. 6-Hydroxydopamine-induced alterations in blood-brain barrier permeability.
    Carvey PM; Zhao CH; Hendey B; Lum H; Trachtenberg J; Desai BS; Snyder J; Zhu YG; Ling ZD
    Eur J Neurosci; 2005 Sep; 22(5):1158-68. PubMed ID: 16176358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
    J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice.
    Zhao C; Ling Z; Newman MB; Bhatia A; Carvey PM
    Neurobiol Dis; 2007 Apr; 26(1):36-46. PubMed ID: 17234424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally.
    Ling Z; Zhu Y; Tong Cw; Snyder JA; Lipton JW; Carvey PM
    Exp Neurol; 2006 Jun; 199(2):499-512. PubMed ID: 16504177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
    J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain.
    Ling ZD; Chang Q; Lipton JW; Tong CW; Landers TM; Carvey PM
    Neuroscience; 2004; 124(3):619-28. PubMed ID: 14980732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A narrow time-window for access to the brain by exogenous protein after immunological targeting of a blood-brain barrier antigen.
    N Ghabriel M; J Lu J; Tadros R; Hermanis G
    J Comp Pathol; 2004 Jul; 131(1):52-60. PubMed ID: 15144799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease.
    Engler H; Doenlen R; Riether C; Engler A; Niemi MB; Besedovsky HO; del Rey A; Pacheco-López G; Feldon J; Schedlowski M
    Brain Behav Immun; 2009 May; 23(4):518-26. PubMed ID: 19486644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons.
    Rite I; Machado A; Cano J; Venero JL
    J Neurochem; 2007 Jun; 101(6):1567-82. PubMed ID: 17437543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
    Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
    Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.
    Marinova-Mutafchieva L; Sadeghian M; Broom L; Davis JB; Medhurst AD; Dexter DT
    J Neurochem; 2009 Aug; 110(3):966-75. PubMed ID: 19549006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
    Sedaghat K; Finkelstein DI; Gundlach AL
    Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in parvalbumin expression in the zona incerta after 6OHDA lesion in rats.
    Heise CE; Mitrofanis J
    J Neurocytol; 2005 Dec; 34(6):421-34. PubMed ID: 16902763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke.
    Guo M; Cox B; Mahale S; Davis W; Carranza A; Hayes K; Sprague S; Jimenez D; Ding Y
    Neuroscience; 2008 Jan; 151(2):340-51. PubMed ID: 18160227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats.
    Wang YQ; Bian GL; Bai Y; Cao R; Chen LW
    Neurochem Int; 2008 Sep; 53(3-4):56-62. PubMed ID: 18639597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a preclinical model of Parkinson's disease: a study of behaviour in rats with graded 6-OHDA lesions.
    Truong L; Allbutt H; Kassiou M; Henderson JM
    Behav Brain Res; 2006 Apr; 169(1):1-9. PubMed ID: 16413939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeability of the blood-brain barrier to protein and [3H]GABA in intraparenchymal fetal CNS tissue grafts.
    Rosenstein JM
    Exp Neurol; 1996 Nov; 142(1):66-79. PubMed ID: 8912899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the blood-brain barrier during TNBS colitis.
    Natah SS; Mouihate A; Pittman QJ; Sharkey KA
    Neurogastroenterol Motil; 2005 Jun; 17(3):433-46. PubMed ID: 15916631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of partial and severe dopaminergic lesion on basal ganglia oscillatory activity and akinesia.
    Tseng KY; Kargieman L; Gacio S; Riquelme LA; Murer MG
    Eur J Neurosci; 2005 Nov; 22(10):2579-86. PubMed ID: 16307600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.